Literature DB >> 25326567

The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney.

B Talbot1, D Wright2, K Basnayake1.   

Abstract

Multiple myeloma (MM) is the second most common haematological malignancy in the UK. We present a case series of three patients with light chain only myeloma who had normal serum protein electrophoretic studies at screening and were diagnosed using serum and urine free light chain assessment. This series reiterates the importance of thorough and robust screening for MM in patients presenting with renal disease. We review the up to date literature and we highlight the need to screen patients for MM with a combination of serum electrophoresis/immunofixation and either urinary or serum free light chain measurement and to maintain a high index of suspicion regardless of the presence or absence of proteinuria. We also discuss the emerging role of the serum free light chain assay. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25326567      PMCID: PMC4202043          DOI: 10.1136/bcr-2014-206688

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.

Authors:  Roshini S Abraham; Raynell J Clark; Sandra C Bryant; James F Lymp; Timothy Larson; Robert A Kyle; Jerry A Katzmann
Journal:  Clin Chem       Date:  2002       Impact factor: 8.327

Review 2.  The biology of immunoglobulin free light chains and kidney injury.

Authors:  Kolitha Basnayake; Stephanie J Stringer; Colin A Hutchison; Paul Cockwell
Journal:  Kidney Int       Date:  2011-04-13       Impact factor: 10.612

Review 3.  Serum free light chain assessment in monoclonal gammopathy and kidney disease.

Authors:  Colin A Hutchison; Kolitha Basnayake; Paul Cockwell
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

4.  Serum test for assessment of patients with Bence Jones myeloma.

Authors:  Arthur R Bradwell; Hugh D Carr-Smith; Graham P Mead; Timothy C Harvey; Mark T Drayson
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 5.  Multiple myeloma: charging toward a bright future.

Authors:  Jed A Katzel; Parameswaran Hari; David H Vesole
Journal:  CA Cancer J Clin       Date:  2007 Sep-Oct       Impact factor: 508.702

6.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

Authors:  Colin A Hutchison; Stephen Harding; Pete Hewins; Graham P Mead; John Townsend; Arthur R Bradwell; Paul Cockwell
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

7.  Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

Authors:  L M Knudsen; E Hippe; M Hjorth; E Holmberg; J Westin
Journal:  Eur J Haematol       Date:  1994-10       Impact factor: 2.997

8.  Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients.

Authors:  Malcolm P McTaggart; Jindriska Lindsay; Edward M Kearney
Journal:  Am J Clin Pathol       Date:  2013-12       Impact factor: 2.493

Review 9.  International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Authors:  A Dispenzieri; R Kyle; G Merlini; J S Miguel; H Ludwig; R Hajek; A Palumbo; S Jagannath; J Blade; S Lonial; M Dimopoulos; R Comenzo; H Einsele; B Barlogie; K Anderson; M Gertz; J L Harousseau; M Attal; P Tosi; P Sonneveld; M Boccadoro; G Morgan; P Richardson; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; W Chen; K Shimizu; R Powles; S V Rajkumar; B G M Durie
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

10.  Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.

Authors:  Colin A Hutchison; Tim Plant; Mark Drayson; Paul Cockwell; Melpomeni Kountouri; Kolitha Basnayake; Stephen Harding; Arthur R Bradwell; Graham Mead
Journal:  BMC Nephrol       Date:  2008-09-22       Impact factor: 2.388

View more
  1 in total

1.  Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test.

Authors:  Jennifer L J Heaney; John P Campbell; Punit Yadav; Ann E Griffin; Meena Shemar; Jennifer H Pinney; Mark T Drayson
Journal:  BMC Nephrol       Date:  2017-07-20       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.